Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 5 Head and Neck Neoplasms 4 Prostatic Neoplasms 3 Urinary Bladder Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Esophageal Squamous Cell Carcinoma 2 Carcinoma, Hepatocellular 2 Brain Neoplasms 2 Thyroid Nodule 1 Spinal Cord Tumor of Cervical Spine 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Retinoblastoma 1 Rectal Neoplasms 1 Pelvic Neoplasms 1 Pathologic Complete Response 1 Parotid Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms 1 Multiple Pulmonary Nodules 1 Mouth Neoplasms 1 Lymphoma 1 Lymphatic Metastasis 1 Lung Neoplasms 1 Glioma 1 Esophageal Neoplasms 1 Disease 1 Colonic Neoplasms 1 Carcinoma, Squamous Cell 1

Interventions

Paclitaxel 35 Carboplatin 35 Bevacizumab 14 olaparib 13 niraparib 11 apatinib 11 Gemcitabine 10 liposomal doxorubicin 9 Hyperthermic Intraperitoneal Chemotherapy 9 Cisplatin 9 pembrolizumab 8 Cyclophosphamide 8 fludarabine 7 Etoposide 7 Topotecan 6 fluzoparib 5 Surveys and Questionnaires 5 Drug Therapy 5 Albumin-Bound Paclitaxel 5 anlotinib 4 Immunohistochemistry 4 Ifosfamide 4 Doxorubicin 4 Docetaxel 4 Cytoreduction Surgical Procedures 4 Taxes 3 Surgical Procedures, Operative 3 Poly(ADP-ribose) Polymerase Inhibitors 3 Neoadjuvant Therapy 3 Laparoscopy 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Ovarian Neoplasms × Magnetic Resonance Imaging × Clear all

NCT03526809 2018-05-16

MISSION-ovary

Cambridge University Hospitals NHS Foundation Trust

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡